Benign Prostate Hyperplasia

Minimally Invasive Techniques for Large-Volume Benign Prostatic Hyperplasia: A Comparative Study Between HoLEP and Robotic Simple Prostatectomy

Silvia Juste-Alvarez, Claudia Zaccaro, Javier Gil-Moradillo, Javier Romero-Otero, Ignacio Moncada, Alfredo Rodríguez-Antolín, Borja García-Gomez

Surgical Techniques Development, May 2025. | DOI: https://doi.org/10.3390/std14020017

Initial experience with thulium fiber laser for prostate enucleation: Analysis of the intraoperative and short-term outcomes in a prospective, multicenter cohort

Javier Romero Otero, Juan Justo Quintas, Esther García Rojo, Raquel Sopeña Sutil, Elena Peña Vallejo, Fernando Lista Mateos, Giorgio Bozzini, David Saenz Calzada, Alfredo Rodríguez Antolín, Borja García Gómez

Spanish Urological Proceedings. 2024 Feb. doi: 10.1016/j.acuroe.2024.02.010

Symptoms of the Lower Urinary Tract in men. A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men with Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) 

Preliminary results of a national multicenter study on the treatment of LUTS secondary to benign prostatic hyperplasia using the Rezum® steam system. 

Fernández-Guzmán E, Asensio Matas A, Capape Poves V, Rioja Zuazu J, Garrido Abad P, Martínez-Salamanca JI, Quintana Franco LM, Justo-Quintas J, Romero-Otero J, Domínguez-Esteban M.

Spanish Urological Acts (Engl Ed). 2022 Jun; 46(5):310-316. doi: 10.1016/j.acuroe. 2021.11.003. Epub 2022 May 12. PMID: 35570100

On Behalf Of The Qualiprost Study Group. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study

Alcaraz A, Castro-Díaz D, Gacci M, Salonia A, Ficarra V, Carballido-Rodríguez J, Rodríguez-Antolín A, Medina-Polo J, Fernández-Gómez JM, Cózar-Olmo JM, Búcar-Terrades S, Pérez-León N, Brenes-Bermúdez FJ, Molero-García JM, Fernández-Pro-Ledesma A, Herdman M, Angulo JC, Manasanch J.

J Clin Med. 2022 Jun 22;11(13):3615. doi:10.3390/jcm11133615. PMID: 35806900; PMCID: PMC9267652

Impact of Surgery for Benign Prostatic Hyperplasia on Sexual Function: A Systematic Review and Meta-analysis of Erectile Function and Ejaculatory Function

Celeste Manfredi, Borja García-Gómez, Javier Romero-Otero, Davide Arcaniolo, Esther García-Rojo, Fabio Crocerossa, Riccardo Autorino, Christian Gratzke, Marco De Sio

European Urology Focus. 2022 Jul 5;S2405-4569(22)00136-5. PMID: 35803852 DOI: 10.1016/j.euf.2022.06.007

HoLEP vs ThuLEP: surgical, functional and sexual outcomes from a randomized controlled trial. 

Javier Romero Otero

Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study

Alcaraz A, Gacci M, Ficarra V, Medina-Polo J, Salonia A, Fernández-Gómez JM, Ciudin A, Castro-Díaz D, Rodríguez-Antolín A, Carballido-Rodríguez J, Cózar-Olmo JM, Búcar-Terrades S, Pérez-León N, Brenes-Bermúdez FJ, Molero-García JM, Ledesma AF, Herdman M, Manasanch J, Angulo JC, Group OBOTQS

Journal of Clinical Medicine. 2022 Feb 12;11(4):967. doi:10.3390/jcm11040967. PMID: 35207238; PMCID: PMC8878824.

Benign prostatic hyperplasia management during COVID-19 pandemic.

José Medina Polo, Julio Téigell Tobar, Javier Romero Otero, Joaquín Carballido Rodríguez, Mario Domínguez Esteban, María Lourdes Martínez-Berganza, Bernardino Miñana-López, Jesús Miguel Unda Urzaiz, Alfredo Rodríguez-Antolín

Spanish Archives of Urology. 2020 Jun;73(5):405-412.

Critical analysis of a multicentric experience with holmium laser enucleation of the prostate for benign prostatic hyperplasia: outcomes and complications of 10 years of routine clinical practice.

J. Romero‐Otero, B. García‐Gómez, L. García‐González, E. García‐Rojo, P. Abad‐López, J. Justo‐Quintas, J. Duarte‐Ojeda, A. Rodríguez‐Antolín

BJU International 2020. Jul;126(1):177-182.

A retrospective analysis comparing persistence and adherence to treatment with free- vs fixed-dose combination of an alpha blocker and an antimuscarinic agent in men with LUTS in Spain.

M. Landeira, Ana M. Mora Blázquez, Rodrigo Martins de Almeida, PJ Covernton, J. Medina-Polo, A. Montero

International Journal of Clinical Practice. 2020 Nov;74(11):e13616.

Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study.

Antonio Alcaraz, Alfredo Rodríguez-Antolín, Joaquín Carballido-Rodríguez, David Castro-Díaz, Manuel Esteban-Fuertes, José M. Cózar-Olmo, Vincenzo Ficarra, Rafael Medina-López, Jesús M. Fernández-Gómez, Javier C. Angulo, José Medina-Polo, Francisco J. Brenes-Bermúdez, José M. Molero-García, Antonio Fernández-Pro-Ledesma, José Manasanch

Journal of Clinical Medicine. 2020 Sep 9;9(9):2909.

Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications. 

Manfredi C, Arcaniolo D, Spatafora P, Crocerossa F, Fusco F, Verze P, Fiori C, Damiano R, Cindolo L, DE Sio M, Romero-Otero J.

Minerva Urol Nephrol. 2021 Jul 26. DOI: 10.23736/S2724-6051.21.04530-4. Epub ahead of print. PMID: 34308611.